BridgeBio Pharma BBIO
NASDAQ BBIO
$79.54 +0.87 (+1.11%)
At close: Nov 11, 2026 · 4:00 PM EST

BridgeBio Pharma (BBIO) Depreciation & Amortization (CF) (2018 - 2026)

Updated

BridgeBio Pharma (BBIO) reported Depreciation & Amortization (CF) of $1.07 million for Q3 2026, down 23.5% from $1.4 million a year earlier but up 1.5% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, BridgeBio Pharma's Depreciation & Amortization (CF) came in at $4.74 million, down 11.6% year-over-year; for FY2025, it came in at $5.43 million, down 10.6% from FY2024.

  • Depreciation & Amortization (CF) has declined for three consecutive years, though with a five-year compound annual growth rate of 30.1% (FY2020 to FY2025).
  • By year, Depreciation & Amortization (CF) came in at $6.08 million in FY2024 (-6.5%), $6.49 million in FY2023 (-4.1%), $6.77 million in FY2022 (+15.9%) and $5.84 million in FY2021 (+301.3%).
  • Five-year quarterly Depreciation & Amortization (CF) spans a low of $1.05 million in Q2 2026 and a high of $1.88 million in Q1 2022.
  • Year over year, Depreciation & Amortization (CF) has now declined in each of the last three quarters, with an average decline of 13.1% over the last eight quarters.
  • The high point for year-over-year Depreciation & Amortization (CF) in five years was Q3 2022 (growth of 520.8%); the low point was Q2 2022 (a decline of 54.6%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $1.05 million (Q2 2026), $1.19 million (Q1 2026) and $1.44 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 BridgeBio Pharma 15.42 Bn 11.64 Bn 332.72 Mn 1.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.07 Mn
Jun 30, 2026 1.05 Mn
Mar 31, 2026 1.19 Mn
Dec 31, 2025 1.44 Mn
Sep 30, 2025 1.40 Mn
Jun 30, 2025 1.32 Mn
Mar 31, 2025 1.28 Mn
Dec 31, 2024 1.37 Mn
Sep 30, 2024 1.54 Mn
Jun 30, 2024 1.57 Mn
Mar 31, 2024 1.60 Mn
Dec 31, 2023 1.59 Mn
Sep 30, 2023 1.64 Mn
Jun 30, 2023 1.64 Mn
Mar 31, 2023 1.63 Mn
Dec 31, 2022 1.66 Mn
Sep 30, 2022 1.65 Mn
Jun 30, 2022 1.58 Mn
Mar 31, 2022 1.88 Mn
Dec 31, 2021 1.53 Mn
API Access

BridgeBio Pharma Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BBIO&period=max&api_key=YOUR_API_KEY